The following words and terms when used in this subchapter
shall have the following meaning unless the context clearly indicates
otherwise.
(1) Department--Department of State Health Services.
(2) Calendar year--January 1 through December 31 of
each year.
(3) Exclusivity--A Federal Drug Administration (FDA)
granted delay on approval of competitor drugs that attaches upon FDA's
approval of a drug.
(4) Patent--A property right issued by the United States
Patent and Trademark Office to exclude others from making, using,
offering for sale, or selling an invention for a limited time.
(5) Patent exclusivity--Rights resulting from a drug
manufacturer holding an unexpired patent, or exclusivity, or both.
|
